about
Performance of maximum inspiratory pressure tests and maximum inspiratory pressure reference equations for 4 race/ethnic groupsStatistical principles for omics-based clinical trialsPartial summary measures of the predictiveness curvePhysical activity and change in estimated GFR among persons with CKD.Fibroblast growth factor-23 and cardiovascular disease in the general population: the Multi-Ethnic Study of Atherosclerosis.Clinical predictors of severe cerebral amyloid angiopathy and influence of APOE genotype in persons with pathologically verified Alzheimer disease.No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease.Fibroblast growth factor-23 and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS).Estimated GFR and circulating 24,25-dihydroxyvitamin D3 concentration: a participant-level analysis of 5 cohort studies and clinical trials.Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease eventsRobustness of Next Generation Sequencing on Older Formalin-Fixed Paraffin-Embedded Tissue.Statistical controversies in clinical research: assessing pathologic complete response as a trial-level surrogate end point for early-stage breast cancer.Paricalcitol does not improve glucose metabolism in patients with stage 3-4 chronic kidney disease.Circulating vitamin D metabolites and kidney disease in type 1 diabetes.Kidney disease and increased mortality risk in type 2 diabetesComparing and combining biomarkers as principle surrogates for time-to-event clinical endpoints.Estimating mean annual 25-hydroxyvitamin D concentrations from single measurements: the Multi-Ethnic Study of Atherosclerosis.Parathyroid hormone and arterial dysfunction in the multi-ethnic study of atherosclerosisCirculating vitamin D metabolites and subclinical atherosclerosis in type 1 diabetesLong-term function in an older cohort--the cardiovascular health study all stars studyTotal and cause-specific mortality in the cardiovascular health study.25-Hydroxyvitamin D and parathyroid hormone are not associated with carotid intima-media thickness or plaque in the multi-ethnic study of atherosclerosis.Serum phosphate is associated with aortic valve calcification in the Multi-ethnic Study of Atherosclerosis (MESA)Association of 25-hydroxyvitamin D and parathyroid hormone with incident hypertension: MESA (Multi-Ethnic Study of Atherosclerosis).Issues in developing multivariable molecular signatures for guiding clinical care decisions.Development and validation of a Luminex assay for detection of a predictive biomarker for PROSTVAC-VF therapy.Evaluation and comparison of predictive individual-level general surrogates.Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.Measuring precision in bioassays: Rethinking assay validation.An Introduction to Principal Surrogate Evaluation with the pseval Package.Comparing and combining biomarkers as principal surrogates for time-to-event clinical endpoints.Optimizing and evaluating biomarker combinations as trial-level general surrogatesIncreased Mortality of Patients with Childhood-onset Inflammatory Bowel Diseases, Compared With the General PopulationGastrointestinal Infection Increases Odds of Inflammatory Bowel Disease in a Nationwide Case-Control StudyA cluster randomised controlled trial of two rounds of mass drug administration in Zanzibar, a malaria pre-elimination setting-high coverage and safety, but no significant impact on transmissionSmall Nucleolar RNA Score: An Assay to Detect Formalin-Overfixed TissueAssociation between inflammatory bowel disease and Parkinson’s disease: seek and you shall find?Inflammatory Bowel Disease and Parkinson’s Disease: A Nationwide Swedish Cohort StudyplotROC: A Tool for Plotting ROC CurvesChanges in inflammatory bowel disease subtype during follow-up and over time in 44,302 patients
P50
Q25930050-BC79082D-57F6-47C5-94B9-2162458B107DQ26786730-A3BC2B09-02DF-49CD-B76D-5F394E3BFC3AQ30553029-FF2FADDF-A85F-4E5A-A31A-A8463271D8A7Q30569755-E717C250-3599-4437-A087-9FB60D6C3169Q33650866-96876933-F075-4DC8-ADC0-54E2E26FF578Q33911295-DE29CD48-B65B-41D9-8C6F-3EFE1C9FA519Q33920648-A14A6FC4-9F39-43C7-8F3F-C3658C9E7271Q33940724-C058691A-1FC8-4294-A5D7-C11E019DC4EFQ33954224-1C0ED897-0A7F-437D-A325-D406AF33F371Q34114912-E09F029E-D523-4171-9A85-E12C9431CDA9Q35722718-4515CDC5-04AF-4FA7-9E00-B4CFC8DAAA22Q36429879-A56F9D2F-91B1-4A8A-BBB2-9E3E757B9E84Q36431285-E44432B6-4089-4787-B63B-56F41A5B48DFQ36442470-2EDCD3B7-EE7F-47BF-A942-EAD6C4655CB2Q36574770-CA1BAE2D-6851-4A02-B648-ED335F64BDB7Q36711209-8F1D1140-24B7-44FB-89F4-ED6C531EB17DQ36840607-64BB27A1-0827-45F7-B4C4-9E37D3613432Q36876254-F0D2537A-B105-4549-B8B0-68903B7CD7C3Q37022548-82628790-9B8C-4653-A5D4-B64C068FDABFQ37329943-C4310958-009D-49A8-8F36-D37695B8A29EQ37413113-8391C6F5-AD92-47A6-B6CB-D88198BF53B0Q37641432-33424E8F-9738-4901-8AA0-AA9764FD63ACQ37711157-F3E7F58E-8B3E-4510-8801-25CCF927F607Q37722933-56AD7029-4D57-4AD1-B931-4EF31F91FE0EQ39454048-0F8553AD-A37C-4107-859A-96DCA50D8E2AQ41238074-12C91DFD-AE39-48FA-8C50-B3DD019201B2Q41992194-E0D449E4-0051-460A-A6DC-4C02256F7055Q47658760-B659FE7A-E585-4EE5-BD01-155BA67BF3DDQ48013840-BA11CE1A-3BD6-4E40-AB8B-9D2343E022AAQ49513361-A7901026-86C7-47EA-BC06-CC90D8635A65Q50511253-298EB151-216B-4179-B369-7C370A0DE210Q57286668-6C8CA081-B506-427D-8D60-2D635B2C8D12Q57813394-2A24D808-E4FE-4B38-B7DC-B30CF558964EQ58590443-ED0E228B-DD30-49B1-8532-B3A13B301B00Q59789597-AFECB9D7-6B84-43F9-9325-AC00E06896CEQ60301505-461B5EFB-C2B6-4664-B5A5-CC6E94BA28C4Q63537276-25AE5871-BAF4-4D41-9CEC-44696A1B41ABQ63537279-697FDF65-FAB7-45DF-A4FF-0C3115A2B6F1Q91242319-FA79A7C6-44B2-44E7-88DF-8F8B82AF7CC7Q91281790-7687F8D3-9020-4F2C-8518-112D6C663C54
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michael C Sachs
@ast
Michael C Sachs
@en
Michael C Sachs
@es
Michael C Sachs
@nl
type
label
Michael C Sachs
@ast
Michael C Sachs
@en
Michael C Sachs
@es
Michael C Sachs
@nl
prefLabel
Michael C Sachs
@ast
Michael C Sachs
@en
Michael C Sachs
@es
Michael C Sachs
@nl
P106
P21
P31
P496
0000-0002-1279-8676